Drugs Starting with A
BioSniper tracks 216 drugs and molecules whose names begin with A — each linked to its developers, clinical trials, indications, and FDA decisions. Data availability reflects the latest successfully ingested source records; source and as-of dates are shown where available.
Browse A–ZA
- a2a/a2b adenosine receptor antagonist incb106385
- ab-1011
- abatacept
- abbv-2001
- abc294640
- abelacimab
- abemaciclib
- abiraterone2
- abrocitinib2
- acalabrutinib2
- acasunlimab
- aceclidine
- acellular tissue engineered vessel
- acetaminophen
- acetazolamide
- acetylcysteine
- acoramidis
- acr-23161
- acr-3681
- actinium ac 225 dotatate ryz101
- actinium ac 225 gpc3-targeted peptide ryz801
- actinium ac 225 sstr2-targeted agent ryz401
- actinium ac 225-dota-anti-steap2 monoclonal antibody azd2284
- activated charcoal
- acyclovir1
- ad-rts-hil-12
- adagrasib1
- adakitug
- adalimumab2
- adavosertib
- adenoviral psa vaccine etbx-071
- adg106
- adg116
- adg206
- adrenaline
- adxs-psa2
- afatinib
- aficamten
- aflibercept
- ag102
- agent-7971
- aglatimagene besadenovec
- al1021
- albendazole
- albuterol1
- albuterol sulfate; budesonide2
- alcestobart
- aldafermin1
- aldesleukin
- alectinib
- alemtuzumab
- alendronate1
- aleniglipron1
- alglucosidase alfa
- alirocumab
- alisertib1
- alk inhibitor nvl-655
- allogeneic cd19-specific universal car19-expressing t-lymphocytes
- allogeneic crispr-cas9 engineered anti-cd19 car t cells ctx110
- allogeneic gamma-delta t-lymphocytes tcb-008
- allogeneic rituximab conjugated gamma delta t-cells ace1831
- allogeneic variable delta 1 gamma-delta t-lymphocytes gdx012
- alpelisib2
- alpha 1-antitrypsin
- alrizomadlin
- aluminum
- aluminum potassium sulfate
- amdizalisib
- amezalpat1
- amifampridine1
- amikacin
- aminocaproic acid
- aminolevulinic acid1
- amivantamab
- amjevita1
- amlitelimab
- amlodipine
- amoxicillin
- amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine2
- ampicillin
- ampreloxetine1
- amrecibart
- amzeeq2
- an9025
- anagrelide
- anakinra
- anastrozole1
- andexanet alfa
- angiotensin ii
- anifrolumab
- anito-cel1
- anitocabtagene autoleucel
- anti-b7-h3 antibody-drug conjugate db-1311
- anti-b7-h4 monoclonal antibody nc762
- anti-b7-h4/anti-4-1bb bispecific antibody cln-4181
- anti-ccr8 antibody-drug conjugate tak-188
- anti-ccr8 monoclonal antibody zl-1218
- anti-cd19-glucosteroid receptor modulator adc abbv-31
- anti-cd19/anti-cd3/anti-cd2 trispecific antibody pit565
- anti-cd20/anti-cd3/anti-cd8 trispecific antibody azd5492
- anti-cd22/anti-cd28 bispecific antibody regn5837
- anti-cd22/topoisomerase i inhibitor antibody-drug conjugate azd4512
- anti-cd30/cd3 bispecific antibody gen3017
- anti-cd33/bet degrader adc abbv-787
- anti-cdh17/exatecan antibody-drug conjugate arr-217
- anti-claudin 18.2 antibody-drug conjugate azd4360
- anti-claudin18.2/anti-cd3 bispecific antibody azd5863
- anti-dectin-2 agonist monoclonal antibody bdc-3042
- anti-egfr antibody-drug conjugate abbv-637
- anti-egfr/anti-c-met monoclonal antibody fpi-2053
- anti-egfr/c-met antibody-drug conjugate gen1286
- anti-epcam/anti-4-1bb bispecific antibody bnt314
- anti-fcrn monoclonal antibody imvt-14022
- anti-galectin-9 monoclonal antibody lyt-200
- anti-gd2 antibody-drug conjugate m3554
- anti-gpc3-car t-lymphocytes tak-102
- anti-gprc5d monoclonal antibody sar446523
- anti-il-18bp monoclonal antibody gs-0321
- anti-ilt4 monoclonal antibody mk-4830
- anti-muc-1/anti-cd40 bispecific antibody m0324
- anti-mutant calreticulin monoclonal antibody inca033989
- anti-mutcalr/anti-cd3 bispecific antibody inca035784
- anti-ox40 agonist monoclonal antibody gen1055
- anti-pd-1/anti-tgfbrii bispecific antibody inca33890
- anti-psma gamma delta t-cell engaging bispecific antibody lava-1207
- anti-psma/steap1 antibody-drug conjugate abbv-969
- anti-ptk7 antibody-drug conjugate skb518
- anti-ptk7/exatecan antibody-drug conjugate day3011
- anti-pvrig monoclonal antibody com701
- anti-ror1 antibody-drug conjugate im-1021
- anti-sirpa monoclonal antibody bi 770371
- anti-steap2 monoclonal antibody azd2275
- anti-steap2/anti-cd3/anti-cd8 trispecific antibody azd6621
- anti-steap2/exatecan antibody-drug conjugate azd0516
- anti-tgf-beta monoclonal antibody sar-439459
- anti-tmprss6 monoclonal antibody disc-3405
- anti-tnfr2 monoclonal antibody bi-1808
- anti-trem2 monoclonal antibody eos0062151
- anti-trop-2 antibody-drug conjugate pbi-410
- antibody-drug conjugate abbv-324
- anzutresgene autoleucel
- apadamtase alfa
- apalutamide
- apf530
- apg -2449
- apitegromab1
- apixaban3
- apl-2
- apraclonidine
- apremilast
- aprepitant
- arc fusion protein sl-279252
- arexvy
- aripiprazole
- aripiprazole lauroxil2
- arlocabtagene autoleucel
- aro-aat
- artemether
- artemether; lumefantrine1
- arx5171
- asciminib1
- asfotase alfa
- asparaginase
- aspirin
- atacicept
- atazanavir2
- atenolol
- atigotatug/nivolumab
- atogepant1
- atoltivimab
- atomoxetine1
- atorvastatin2
- atovaquone
- atrasentan2
- atropine
- aurora a kinase/tyrosine kinase inhibitor enmd-2076
- auryxia1
- autologous anti-bcma car t-cells phe885
- autologous anti-cd19 car-t cells caba-2011
- autologous anti-claudin18.2 car t-cells lb1908
- autologous anti-dll3 car-t cells lb2102
- autologous anti-mesothelin car-il-7-ccl19-expressing t-lymphocytes tak-103
- autologous base edited cd34+ hspcs beam-101
- autologous bispecific bcma/cd19-targeted car-t cells gc012f
- autologous car-engineered regulatory t-cells sbt777101
- autologous cd34-positive bcl11a-disrupted hematopoietic progenitor cells bivv003
- autologous crispr-cas9 engineered regnase-1/socs1 dual-edited tumor infiltrating lymphocytes ksq-004ex
- autologous crispr-cas9 engineered tumor infiltrating lymphocytes ksq-001ex
- autologous dntgf-brii-armored anti-gpc3 car t-cells azd5851
- autologous dntgf-brii-armored anti-steap2 car t-cells azd0754
- autologous kras g12d-specific hla-c*08:02-restricted tcr gene engineered t-lymphocytes nt-112
- autologous peripheral blood lymphocytes from ibrutinib-treated chronic lymphocytic leukemia patients iov-2001
- autologous tumor infiltrating lymphocytes ln-145
- auvelity1
- avacincaptad pegol1
- avacopan
- avalglucosidase alfa
- avapritinib2
- avelumab
- avexitide2
- avibactam
- avlayah3
- avmapki fakzynja co-pack1
- avutometinib1
- axatilimab1
- axicabtagene ciloleucel
- axitinib1
- axl/mer inhibitor incb081776
- azacitidine
- azathioprine
- azd4635
- azedra1
- azenosertib1
- azetukalner1
- azilsartan
- azithromycin
From drug list to evidence case
Define what these drug programs must prove
Choose the developer, phase, trial, indication, and FDA evidence that should count in your drug thesis.